B. Douglas Smith

Characterization of clonogenic multiple myeloma cells

William Matsui, Carol Ann Huff, Qiuju Wang et al. · Blood · 2003 · 792 citations · Full text

Medicine, Cell Biology, Oncology +12

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

B. Douglas Smith, Mark J. Levis, Miloslav Beran et al. · Blood · 2004 · 629 citations

Medicine, Oncology, Pharmacology +11

Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

William Matsui, Qiuju Wang, James Barber et al. · Cancer Research · 2008 · 538 citations · Full text

Medicine, Oncology, Pharmacology +15

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

Jörge E. Cortes, Florian H. Heidel, Andrzej Hellmann et al. · Leukemia · 2018 · 489 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

Mark J. Levis, Jeffrey Allebach, Kam-Fai Tse et al. · Blood · 2002 · 474 citations

Medicine, Oncology, Pharmacology +11